series c+
Stage
2019
Founded
3
Investors
About
Kriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide. Learn more.
Explore Kriya's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.